BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
DEFA1 |
P59665
|
defensin alpha 1
|
|
|
0.636 |
0.731 |
HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IFNA17 |
P01571
|
interferon alpha 17
|
|
|
0.636 |
0.615 |
IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |